Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -8.47% vs -20.37% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -50.77% vs -23.87% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -22.28% vs -53.42% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 111.76% vs -27.66% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Zhejiang Shouxiangu Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -21.43% vs 57.01% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -8.47% vs -20.37% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 149.40% vs -641.67% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -50.77% vs -23.87% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -22.28% vs -53.42% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 111.76% vs -27.66% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






